Drug Delivery Technology Market Size, Share, Competitive Landscape and Trend Analysis Report, by Type and, by End-User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Drug delivery system is the process to administer therapeutic substance through common route of administration to achieve a therapeutic effect in humans or animals. Drugs delivery technology controls the rate and time of the drug released in the body thus improving the efficacy of the drug.

Increase in prevalence of chronic diseases, demand for biologics, and technological advancements majorly drive the market. In addition, increase in demand for biosimilar and generic drugs have boost the market growth. However, risk of needle-stick injuries and side effects of drugs restrict the market growth.

The report segments the drug delivery systems market based on route of administration, end-user, and geography. According to the route of administration, it is segmented as oral route, parenteral route, transdermal route, inhalation route, and nasal drug delivery. Parenteral route is further categorized into intramuscular, intravenous, intra-arterial, and subcutaneous route. By end-user, it is divided into clinics, diagnostic centers, and home care settings. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major key players operating in this market include Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., 3M Company, and F. Hoffmann-La Roche Ltd.

Key Benefits for Stakeholders

• This report offers an extensive analysis of the current trends and emerging estimations of the global drug delivery technology market, which assist to identify the prevailing opportunities.
• Comprehensive analysis of all geographical regions is provided, along with factors that drive and restrict the market growth.
• Quantitative analysis of the market is provided to showcase the financial scenario of the market.
• The market conditions are comprehensively analyzed region- and country-wise.

  Drug Delivery Technology Market Report Highlights

Aspects	Details
By Type	Oral Route Parenteral Route Transdermal Route Inhalation Route Nasal Drug Delivery
By End-User	Hospitals Clinics Diagnostic Centers Home Care Settings Others
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	BD (Becton, Dickinson and Company), Medtronic, Nemara, Ypsomed, Gerresheimer AG, West Pharmaceutical Services Inc., E3D Elcam Drug Delivery Devices, Kindeva Drug Delivery, Baxter

Author Name(s) : Deepa Tatkare | Roshan Deshmukh

^*Terms and Conditions Apply